{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:05:56Z","timestamp":1794409556399,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Fund","award":["82074539"],"award-info":[{"award-number":["82074539"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19209-x","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:31:35Z","timestamp":1759923095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["NSUN7-mediated m5C methylation of NLRP3 promotes pyroptosis in ovarian granulosa cells in polycystic ovary syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Guobin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiansong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"19209_CR1","doi-asserted-by":"publisher","first-page":"E206","DOI":"10.15167\/2421.4248\/jpmh2022.63.2S3.2762","volume":"63","author":"AK Kiani","year":"2022","unstructured":"Kiani, A. K., Donato, K., Dhuli, K., Stuppia, L. & Bertelli, M. Dietary supplements for polycystic ovary syndrome. J. Prev. Med. Hyg. 63, E206\u2013E213. https:\/\/doi.org\/10.15167\/2421.4248\/jpmh2022.63.2S3.2762 (2022).","journal-title":"J. Prev. Med. Hyg."},{"key":"19209_CR2","doi-asserted-by":"publisher","first-page":"100494","DOI":"10.1016\/j.lanwpc.2022.100494","volume":"25","author":"R Yang","year":"2022","unstructured":"Yang, R. et al. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg. Health West. Pac. 25, 100494. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100494 (2022).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"19209_CR3","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-23-0342","author":"J Yang","year":"2024","unstructured":"Yang, J. & Chen, C. Hormonal changes in PCOS. J. Endocrinol. https:\/\/doi.org\/10.1530\/JOE-23-0342 (2024).","journal-title":"J. Endocrinol."},{"key":"19209_CR4","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger, K. M., Dokras, A. & Piltonen, T. Update on PCOS: consequences, challenges, and guiding treatment. J. Clin. Endocrinol. Metab. 106, e1071\u2013e1083. https:\/\/doi.org\/10.1210\/clinem\/dgaa839 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"19209_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041454","author":"S Singh","year":"2023","unstructured":"Singh, S. et al. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm12041454 (2023).","journal-title":"J. Clin. Med."},{"key":"19209_CR6","doi-asserted-by":"publisher","first-page":"1191759","DOI":"10.3389\/fendo.2023.1191759","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang, K. & Li, Y. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front. Endocrinol. (Lausanne). 14, 1191759. https:\/\/doi.org\/10.3389\/fendo.2023.1191759 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"19209_CR7","doi-asserted-by":"publisher","first-page":"111141","DOI":"10.1016\/j.intimp.2023.111141","volume":"125","author":"Y Xiang","year":"2023","unstructured":"Xiang, Y. et al. Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia. Int. Immunopharmacol. 125, 111141. https:\/\/doi.org\/10.1016\/j.intimp.2023.111141 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"19209_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu, P. et al. Pyroptosis: mechanisms and diseases. Signal. Transduct. Target. Ther. 6, 128. https:\/\/doi.org\/10.1038\/s41392-021-00507-5 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"19209_CR9","doi-asserted-by":"publisher","first-page":"1169232","DOI":"10.3389\/fimmu.2023.1169232","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang, J., Yin, T. & Liu, S. Dysregulation of immune response in PCOS organ system. Front. Immunol. 14, 1169232. https:\/\/doi.org\/10.3389\/fimmu.2023.1169232 (2023).","journal-title":"Front. Immunol."},{"key":"19209_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/humrep\/deae066","volume":"39","author":"C Vatier","year":"2024","unstructured":"Vatier, C. & Christin-Maitre, S. Epigenetic\/circadian clocks and PCOS. Hum. Reprod. 39, 1167\u20131175. https:\/\/doi.org\/10.1093\/humrep\/deae066 (2024).","journal-title":"Hum. Reprod."},{"key":"19209_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-023-00139-x","volume":"4","author":"L Qiu","year":"2023","unstructured":"Qiu, L., Jing, Q., Li, Y. & Han, J. RNA modification: mechanisms and therapeutic targets. Mol. Biomed. 4, 25. https:\/\/doi.org\/10.1186\/s43556-023-00139-x (2023).","journal-title":"Mol. Biomed."},{"key":"19209_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-023-01785-z","volume":"22","author":"V Ortiz-Barahona","year":"2023","unstructured":"Ortiz-Barahona, V. et al. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer. Mol. Cancer. 22, 83. https:\/\/doi.org\/10.1186\/s12943-023-01785-z (2023).","journal-title":"Mol. Cancer"},{"key":"19209_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10815-015-0443-0","volume":"32","author":"N Khosronezhad","year":"2015","unstructured":"Khosronezhad, N., Hosseinzadeh, C. A. & Mortazavi, S. M. The Nsun7 (A11337)-deletion mutation, causes reduction of its protein rate and associated with sperm motility defect in infertile men. J. Assist. Reprod. Genet. 32, 807\u2013815. https:\/\/doi.org\/10.1007\/s10815-015-0443-0 (2015).","journal-title":"J. Assist. Reprod. Genet."},{"key":"19209_CR14","doi-asserted-by":"publisher","first-page":"1231898","DOI":"10.3389\/fimmu.2023.1231898","volume":"14","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Identification and validation of key biomarkers based on RNA methylation genes in sepsis. Front. Immunol. 14, 1231898. https:\/\/doi.org\/10.3389\/fimmu.2023.1231898 (2023).","journal-title":"Front. Immunol."},{"key":"19209_CR15","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s12035-022-03195-6","volume":"60","author":"A PerezGrovas-Saltijeral","year":"2023","unstructured":"PerezGrovas-Saltijeral, A., Rajkumar, A. P. & Knight, H. M. Differential expression of m(5)C RNA methyltransferase genes NSUN6 and NSUN7 in alzheimer\u2019s disease and traumatic brain injury. Mol. Neurobiol. 60, 2223\u20132235. https:\/\/doi.org\/10.1007\/s12035-022-03195-6 (2023).","journal-title":"Mol. Neurobiol."},{"key":"19209_CR16","doi-asserted-by":"publisher","unstructured":"Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41\u201347. (2003). https:\/\/doi.org\/10.1093\/humrep\/deh098","DOI":"10.1093\/humrep\/deh098"},{"key":"19209_CR17","doi-asserted-by":"publisher","first-page":"967151","DOI":"10.3389\/fimmu.2022.967151","volume":"13","author":"W Tan","year":"2022","unstructured":"Tan, W. et al. MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome. Front. Immunol. 13, 967151. https:\/\/doi.org\/10.3389\/fimmu.2022.967151 (2022).","journal-title":"Front. Immunol."},{"key":"19209_CR18","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/fsn3.3973","volume":"12","author":"H Lan","year":"2024","unstructured":"Lan, H. et al. Sinapic acid modulates oxidative stress and metabolic disturbances to attenuate ovarian fibrosis in letrozole-induced polycystic ovary syndrome SD rats. Food Sci. Nutr. 12, 2917\u20132931. https:\/\/doi.org\/10.1002\/fsn3.3973 (2024).","journal-title":"Food Sci. Nutr."},{"key":"19209_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphar.2020.01030","volume":"11","author":"J Wei","year":"2020","unstructured":"Wei, J. & Zhao, Y. MiR-185-5p protects against angiogenesis in polycystic ovary syndrome by targeting VEGFA. Front. Pharmacol. 11, 1030. https:\/\/doi.org\/10.3389\/fphar.2020.01030 (2020).","journal-title":"Front. Pharmacol."},{"key":"19209_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/toxsci\/kfaa045","volume":"176","author":"IV Sarmento","year":"2020","unstructured":"Sarmento, I. V. et al. Subchronic and low dose of tributyltin exposure leads to reduced ovarian reserve, reduced uterine gland number, and other reproductive irregularities in female mice. Toxicol. Sci. 176, 74\u201385. https:\/\/doi.org\/10.1093\/toxsci\/kfaa045 (2020).","journal-title":"Toxicol. Sci."},{"key":"19209_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40659-023-00441-6","volume":"56","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Acupuncture regulates the apoptosis of ovarian granulosa cells in polycystic ovarian syndrome-related abnormal follicular development through LncMEG3-mediated Inhibition of miR-21-3p. Biol. Res. 56, 31. https:\/\/doi.org\/10.1186\/s40659-023-00441-6 (2023).","journal-title":"Biol. Res."},{"key":"19209_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13148-023-01487-9","volume":"15","author":"K Liu","year":"2023","unstructured":"Liu, K. et al. Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome. Clin. Epigenetics. 15, 86. https:\/\/doi.org\/10.1186\/s13148-023-01487-9 (2023).","journal-title":"Clin. Epigenetics"},{"key":"19209_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13048-023-01246-7","volume":"16","author":"L Zou","year":"2023","unstructured":"Zou, L., Li, W., Xu, D., Zhu, S. & Jiang, B. Alteration of the N(6)-methyladenosine methylation landscape in a mouse model of polycystic ovary syndrome. J. Ovarian Res. 16, 157. https:\/\/doi.org\/10.1186\/s13048-023-01246-7 (2023).","journal-title":"J. Ovarian Res."},{"key":"19209_CR24","doi-asserted-by":"publisher","first-page":"e1137","DOI":"10.1002\/ctm2.1137","volume":"12","author":"C Ding","year":"2022","unstructured":"Ding, C. et al. RNA-methyltransferase Nsun5 controls the maternal-to-zygotic transition by regulating maternal mRNA stability. Clin. Transl Med. 12, e1137. https:\/\/doi.org\/10.1002\/ctm2.1137 (2022).","journal-title":"Clin. Transl Med."},{"key":"19209_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00018-025-05709-6","volume":"82","author":"Q Chen","year":"2025","unstructured":"Chen, Q. et al. Aberrant downregulation of Y-box binding protein 1 expression impairs the cell cycle in an m(5)C-dependent manner in human granulosa cells from patients with primary ovarian insufficiency. Cell. Mol. Life Sci. 82, 206. https:\/\/doi.org\/10.1007\/s00018-025-05709-6 (2025).","journal-title":"Cell. Mol. Life Sci."},{"key":"19209_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/genes10020102","author":"KE Bohnsack","year":"2019","unstructured":"Bohnsack, K. E., Hobartner, C. & Bohnsack, M. T. Eukaryotic 5-methylcytosine (m(5)C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease. Genes (Basel) https:\/\/doi.org\/10.3390\/genes10020102 (2019).","journal-title":"Genes (Basel)"},{"key":"19209_CR27","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s43032-023-01348-z","volume":"31","author":"B Wang","year":"2024","unstructured":"Wang, B. et al. NLRP3 Inflammasome-dependent pathway is involved in the pathogenesis of polycystic ovary syndrome. Reprod. Sci. 31, 1017\u20131027. https:\/\/doi.org\/10.1007\/s43032-023-01348-z (2024).","journal-title":"Reprod. Sci."},{"key":"19209_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-022-03427-2","volume":"20","author":"M Li","year":"2022","unstructured":"Li, M. et al. 5-methylcytosine RNA methyltransferases and their potential roles in cancer. J. Transl Med. 20, 214. https:\/\/doi.org\/10.1186\/s12967-022-03427-2 (2022).","journal-title":"J. Transl Med."},{"key":"19209_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll, R. C., Schroder, K. & Pelegrin, P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol. Sci. 43, 653\u2013668. https:\/\/doi.org\/10.1016\/j.tips.2022.04.003 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"19209_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaad035","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Inflammasomes in human reproductive diseases. Mol. Hum. Reprod. https:\/\/doi.org\/10.1093\/molehr\/gaad035 (2023).","journal-title":"Mol. Hum. Reprod."},{"key":"19209_CR31","doi-asserted-by":"publisher","first-page":"e23592","DOI":"10.1002\/jbt.23592","volume":"38","author":"S Chamanara","year":"2024","unstructured":"Chamanara, S., Hozouri, V. & Irandoost, E. Inhibition of NLRP3 inflammasome-A potential mechanistic therapeutic for treatment of polycystic ovary syndrome? J. Biochem. Mol. Toxicol. 38, e23592. https:\/\/doi.org\/10.1002\/jbt.23592 (2024).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"19209_CR32","doi-asserted-by":"publisher","first-page":"e2300784","DOI":"10.1002\/mnfr.202300784","volume":"68","author":"K Liu","year":"2024","unstructured":"Liu, K. et al. alpha-Ketoglutarate improves ovarian reserve function in primary ovarian insufficiency by inhibiting NLRP3-Mediated pyroptosis of granulosa cells. Mol. Nutr. Food Res. 68, e2300784. https:\/\/doi.org\/10.1002\/mnfr.202300784 (2024).","journal-title":"Mol. Nutr. Food Res."},{"key":"19209_CR33","doi-asserted-by":"publisher","first-page":"103814","DOI":"10.1016\/j.rbmo.2024.103814","volume":"48","author":"J Xie","year":"2024","unstructured":"Xie, J. et al. Exosomes derived from mesenchymal stem cells attenuate NLRP3-related pyroptosis in autoimmune premature ovarian insufficiency via the NF-kappaB pathway. Reprod. Biomed. Online. 48, 103814. https:\/\/doi.org\/10.1016\/j.rbmo.2024.103814 (2024).","journal-title":"Reprod. Biomed. Online"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19209-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19209-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19209-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:31:36Z","timestamp":1759923096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19209-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19209"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19209-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Harbin Red Cross Center Hospital. Informed consent was obtained from all individual participants included in the study. This study was performed in line with the principles of the Declaration of Helsinki. All animal experiments should comply with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"35145"}}